Drugs / 500mg IM days 1, 15, 29 (cycle 2 day 1) and then every 4 weeks
500mg IM days 1, 15, 29 (cycle 2 day 1) and then every 4 weeks
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03310541 Background | Oct 2017 → May 2023 | breast cancer, prostate cancer | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 500mg IM days 1, 15, 29 (cycle 2 day 1) and then every 4 weeks | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03310541 ↗ |
| Route | Intramuscular | “500mg IM days 1, 15, 29 (cycle 2 day 1) and then every 4 weeks” NCT03310541 ↗ |